| MR编号 | IE/H/0742/001 |
|---|
| 药品名称 | lrinotecan 20 mg/ml Solutionfor Infusion
40 mg/2 ml and 100 mg/S ml Vials |
|---|
| 活性成分 | - irinotecan hydrochloride 20.0 mg/ml
|
|---|
| 剂型 | Solution for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Oncology Plc
Lion Court
Farnham Road
Bordon
Hampshire
GU35 ONF
United Kingdom |
|---|
| 参考成员国 - 产品名称 | Ireland (IE) |
|---|
| 互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
- Denmark (DK)
- Spain (ES)
- Italy (IT)
- Finland (FI)
- Latvia (LV)
- Lithuania (LT)
Irinotecan Dabur 20 mg/ml infuzinis tirpalas - Estonia (EE)
- Hungary (HU)
Irinotecan-Dabur old. inf. 20mg/ml - Czechia (CZ)
- Slovakia (SK)
Irinotecan 20mg/ml infúzny intravenózmy roztok - Poland (PL)
|
|---|
| 许可日期 | 2008/04/05 |
|---|
| 最近更新日期 | 2024/04/11 |
|---|
| 药物ATC编码 | |
|---|